Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Mirna Swayden

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5003793862. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 2 papers · 2019: 2 papers

Papers 4

  1. PML hyposumoylation is responsible for the resistance of pancreatic cancer. Co-author DOI 10.1096/fj.201901091r↗
  2. Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2019.01443↗
  3. Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype. Co-author DOI 10.1016/j.heliyon.2018.e01055↗
  4. Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma. First author DOI 10.18632/oncotarget.25745↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Philippe Soubeyran · 4 shared papers, 2018–2019 · strength 0.47
  2. Juan Iovanna · 4 shared papers, 2018–2019 · strength 0.47
  3. Odile Gayet · 2 shared papers, 2018–2019 · strength 0.17
  4. Daniele Fanale · 1 shared paper, 2018 · strength 0.09
  5. Jennifer Bintz · 1 shared paper, 2018 · strength 0.09
  6. María Inés Molejon · 1 shared paper, 2018 · strength 0.09
  7. Julie Roques · 1 shared paper, 2019 · strength 0.08
  8. Rawand Masoud · 1 shared paper, 2019 · strength 0.08
  9. Yolande Berthois · 1 shared paper, 2019 · strength 0.08
  10. Nelson Dusetti · 1 shared paper, 2019 · strength 0.08
  11. Alice Carrier · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.